Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
RSC Medicinal Chemistry|November 17, 2023
Novel piperazine-1,2,3-triazole leads for the potential treatment of pancreatic cancerJufeng Sun, Jennifer R Baker, Cecilia C Russell, et al.Molecular Cancer Therapeutics|June 24, 2010
The dynamin inhibitors MiTMAB and OcTMAB induce cytokinesis failure and inhibit cell proliferation in human cancer cellsSanket Joshi, Swetha Perera, Jayne Gilbert, et al.RSC Medicinal Chemistry|March 26, 2026
From bolinaquinone, a marine hydroxyquinone sesquiterpene, to naphthoquinones with clathrin inhibitory effectsNicholas S O'Brien, Azadeh Ghods, Jing Xue, et al.Chemmedchem|December 7, 2016
Cytotoxicity of a Series of Norcantharidin-Inspired Tetrahydroepoxyisoindole CarboxamidesLawson K Spare, Pasquale Falsetta, Jayne Gilbert, et al.Journal of Medicinal Chemistry|May 23, 2009
Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indolesTimothy A Hill, Christopher P Gordon, Andrew B McGeachie, et al.Journal of Medicinal Chemistry|December 21, 2016
Pyrimidine-Based Inhibitors of Dynamin I GTPase Activity: Competitive Inhibition at the Pleckstrin Homology DomainLuke R Odell, Mohammed K Abdel-Hamid, Timothy A Hill, et al.International Journal of Molecular Sciences|February 21, 2019
o-Vanillin Derived Schiff Bases and Their Organotin(IV) Compounds: Synthesis, Structural Characterisation, In-Silico Studies and CytotoxicityEnis Nadia Md Yusof, Muhammad A M Latif, Mohamed I M Tahir, et al.Chemmedchem|November 18, 2025
Substituted Benzylidene-3-Oxo-3,4-Dihydro-2H-Benzo[b][1,4]thiazine-6-Carboxylic Acid Analogs as Dynamin GTPase InhibitorsAndrew J S Lin, Nicholas S O'Brien, Abigail Florence, et al.Journal of Medicinal Chemistry|December 8, 2022
Novel Platinum(II) and Platinum(IV) Antitumor Agents that Exhibit Potent Cytotoxicity and SelectivityAleen Khoury, Elias Elias, Stephanie Mehanna, et al.ACS Chemical Biology|May 7, 2013
Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitorsAndrew B McGeachie, Luke R Odell, Annie Quan, et al.Pageof 8